India Today CENTER (0.0) Reliability: 7.0/10

Killer Syrup Scandal: Congress's Karthi Chidambaram Slams Ally DMK Govt in Tamil Nadu

📅 October 14, 2025 12:00 AM 🕐 Scraped: October 14, 2025

Summary: The focus is on the political fallout from the deaths of at least 22 children in Madhya Pradesh, linked to a contaminated cough syrup manufactured by Tamil Nadu-based Sresan Pharmaceuticals. Congress MP Karthi Chidambaram has questioned the DMK-led government in Tamil Nadu, of which his party is an ally, demanding accountability. Chidambaram stated, 'It is most distressing to note that more than 22 children have passed away because they were administered spurious cough syrup.' The controversy centres on how the syrup, Coldrif, was approved despite containing lethal levels of diethylene glycol (DEG). While the Tamil Nadu government has suspended two drug inspectors and cancelled the manufacturer's licence, the incident has created tension within the ruling alliance and sparked a blame game between state and central authorities.

This special report focuses on the unprecedented surge in silver prices in India, which are outpacing gold, and the resulting supply cr

📰

Continue Reading on India Today

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Not specified

Original Publisher

🌍 India Today

CENTER Bias (0.0)

Published Date

October 14, 2025 at 12:00 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.

Desktop Only